Daniel C. Adelman M.D., Chief Medical Officer at Aimmune Therapeutics, Inc. (AIMT), sold 3,283 shares at $40.00 ($131K) on 2017-12-27, disclosed to the SEC on 2017-12-29.
Open-market sale of $131k AIMT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AIMT | SELL | 2018-01-16 | $1.5M | — | Filing → |
| AIMT | SELL | 2017-10-25 | $575K | — | Filing → |
| AIMT | SELL | 2017-09-27 | $250K | — | Filing → |